In addition, FCER2 is expressed in subsets of B cells and in particular depicts follicular dendritic cell networks [42], whereas expression changes in urine could reflect an altered immune microenvironment in prostate adenocarcinoma patients. The gene discussed is FCER2; the disease is prostate adenocarcinoma.